Compared with placebo, sodium zirconium cyclosilicate was associated with less need to lower or discontinue spironolactone.

For those with chronic kidney disease or who are taking ACE inhibitors or angiotensin receptor blockers, excess potassium can be harmful because the kidneys’ suboptimal functioning hinders them ...

In patients with heart failure with mildly reduced or preserved ejection fraction, finerenone, a nonsteroidal mineralocorticoid receptor antagonist, resulted in more frequent hyperkalemia and less ...

As serum potassium levels rise ... and use of ACE inhibitors or β-antagonists, but not for ACE inhibitor dosage. Ten percent of the study patients developed severe hyperkalemia (≥6.0 meq ...

In patients with heart failure with mildly reduced or preserved ejection fraction, finerenone, a nonsteroidal mineralocorticoid ...